Illustration with science equipment and graduation cap
BY LARISA CIOACA
University research plays a major role in corporate innovation, just not in the way you might expect

Federal funding for university research is often debated as a matter of government spending. To justify the expense, lawmakers want to know that they’re supporting science that will benefit the public in real and measurable ways.

One of the primary ways that university research benefits the public is by crossing over into the corporate world. Businesses utilize the research and inventions produced at universities to introduce new products or improve existing ones, and they also hire university-trained scientists and engineers to lead their internal R&D efforts.

The scale of university science has changed substantially in recent decades. Between 1981 and 2016, science and engineering publications from U.S. universities increased by about 75%, the number of hard-science PhD graduates doubled, and university patenting increased roughly 25-fold. In an ideal world, we would see a direct relationship between the growth of university science and the level of corporate innovation, but these outputs affect businesses in different ways.

In a new study with Ashish Arora, Sharon Belenzon, Lia Sheer and Hansen Zhang, I examined how university publications, PhD graduates and patents influence innovation in established U.S. firms. Our analysis covered 3,372 publicly traded firms conducting R&D between 1986 and 2015. We measured corporate innovation through patents, scientific publications, R&D spending, and the employment of prominent scientists and engineers. We then identified the university science most closely related to each firm’s existing research and technology portfolio.

Our results challenge the conventional wisdom that university research automatically spills over into business once it is published. For the average established firm, an increase in relevant university publications produced little immediate change in corporate patenting or publishing. This pattern persisted when we examined highly cited papers, publications associated with Nobel Prize-winning research, and effects appearing after longer lags.

But this lack of direct effect shouldn’t be interpreted to mean that university publications are unimportant. Scientific papers sustain the university research environment that produces both PhD graduates and patented technologies. Their effects may also emerge over longer periods or travel through collaborations, startups and informal exchanges that are difficult to observe. Moreover, access to published knowledge itself is often insufficient. Firms must possess the internal expertise needed to understand and apply it, and that’s where we see the greatest benefit of university science.

Headshot smiling womanWhen universities produced more PhD graduates whose dissertations were closely related toa firm’s technology, that firm subsequently patented and published more, invested more in R&D, and employed more prominent scientists and engineers. A one-standard-deviation increase in relevant PhD graduates increased corporate patents by approximately 53%, publications by 22% and R&D spending by 33%.

PhD graduates provide an important channel through which university science reaches companies. They bring specialized knowledge into corporate laboratories and strengthen firms’ capacity to conduct research and develop new technologies.

University patents, however, produced a different response. A one-standard-deviation increase in relevant university patents reduced established firms’ patents by approximately 51% and their scientific publications by 33%. University patenting also reduced the value of established firms in our sample. This evidence is consistent with university inventions substituting for internal corporate invention or enabling innovation by other firms, including startups, rather than reinforcing the research of established firms.

This doesn’t mean that university patents reduce innovation across the economy. Rather, university inventions might support new ventures, be licensed to private companies or create competition that shifts innovative activity away from incumbents. Our study focused on established public firms, so it could not capture all the value created elsewhere in the innovation system.

The average results also conceal important differences across industries and firms. University publications contributed more directly to corporate innovation in the life sciences, where scientific research is closely connected to drug and biotechnology development. Publications also complemented research in firms operating near the technological frontier. These companies appear to possess the internal scientific capabilities required to effectively use new academic
knowledge. Firms that have withdrawn from scientific research may be less able to do so.

These distinctions matter when policymakers evaluate federal research budgets. University science should not be judged solely based on the number of papers or patents it produces. Its contribution to business innovation also depends on the supply of scientifically trained workers, the pathways through which inventions are commercialized, and the capabilities firms maintain to absorb external knowledge.

The business case for university science does not rest on a single path from a federal grant to a commercial product. University science produces knowledge, people and inventions. For established firms, our findings show that university-trained scientists provide the clearest direct connection between academic research and corporate innovation — a connection policymakers risk overlooking when university research is evaluated only on the basis of the papers and patents it produces.